NCT01750918 · Interventional trial
BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)
Overall registry status Completed
Phase 1 · Phase 2
Conditions Cancer
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory